MedPath

Male External Catheters' Comparison of Comfort and Efficacy

Not Applicable
Completed
Conditions
Non-invasive Urine Output Management
Interventions
Device: PureWick Male External Catheter
Device: Sage PrimoFit
Registration Number
NCT05955560
Lead Sponsor
C. R. Bard
Brief Summary

A Prospective, Randomized, Crossover, Single-blind, Single Center Healthy Volunteer Study conducted over 1 day, with 2 voids using the PureWick (PW) Male external catheter (MEC) vs. comparator Sage PrimoFit™. This study is designed to assess the performance, comfort, and ease of use of the PW Male external catheter as compared to the comparator product.

Detailed Description

In this prospective, post-market, crossover, single-blind, single center healthy volunteer study, healthy males will be randomized 1:1 to a treatment sequence using two devices (PureWick™ Male External Catheter and Sage PrimoFit™) and followed for 1 day through 2 voids. Approximately 50 participants will be enrolled in this study to obtain 44 evaluable subjects. This study is designed to assess the performance, comfort, and ease of use of the PW Male external catheter.

The purpose of this study is to provide clinical evidence to compare the effectiveness and comfort of PureWick™ Male against a comparator for non-invasive urine output management in patients with varying male anatomy. Specifically, the study will collect data about how the male external catheters perform when participants are positioned on their side using a turning wedge with the head of the bed elevated, mimicking common patient positioning in the hospital setting.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
59
Inclusion Criteria
  1. Adult Male Patient ≥ 18 years old
  2. Male anatomy at time of enrollment
  3. Ability to speak and understand English
  4. Willing to comply with all study procedures in this protocol
  5. Able to independently void urine
  6. Provision of signed and dated informed consent form
Exclusion Criteria
  1. Urinary incontinence which does not allow the subject to spontaneously void
  2. Frequent episodes of bowel incontinence
  3. Has Urinary Retention
  4. Has any irritation, wound, open lesion, at the application site, on the genitalia, perineum, or sacrum
  5. Recent surgery of the external urogenital tract, penis, or pubic area
  6. Not able to comply with study procedures independently without required assistance
  7. Any other condition that, in the opinion of the investigator, would preclude them from participating in the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Treatment Sequence 2PureWick Male External CatheterThe Sage PrimoFit™ is used first, followed by cross-over to PureWick MEC.
Treatment Sequence 1PureWick Male External CatheterPureWick™ Male External Catheter is used first, followed by cross-over to Sage PrimoFit.
Treatment Sequence 2Sage PrimoFitThe Sage PrimoFit™ is used first, followed by cross-over to PureWick MEC.
Treatment Sequence 1Sage PrimoFitPureWick™ Male External Catheter is used first, followed by cross-over to Sage PrimoFit.
Primary Outcome Measures
NameTimeMethod
Performance of the PureWick MEC Against an Established ComparatorApproximately 2 hours after device placement

Capture rate following void (captured as % of urine captured by device and collected in canister, measured by weight).

Prior to each void, the weight of the empty urine collection canister and the weight of a dry absorbent pad are collected. Participants void into the device while laying in a bed with the absorbent pad underneath them. After each void, the post-void weight of the urine collection canister and the post-void weight of the absorbent pad are collected.

Capture rate is calculated as the weight of captured urine (post-void canister weight - pre-void canister weight) / total urine volume (captured urine (post-void canister weight - pre-void canister weight) + leaked urine (post-void pad weight - pre-void pad weight)) \* 100.

Secondary Outcome Measures
NameTimeMethod
Performance of the PureWick MEC in Morbidly Obese SubpopulationApproximately 2 hours after device placement

Capture rate following void (captured as % of urine captured by device and collected in canister, measured by weight).

Participant ComfortApproximately 2 hours after device placement

Overall comfort on a 5-point Likert scale ranging from 1- 5 with higher scores indicating a better outcome, where 1 = Very Uncomfortable, 2 = Uncomfortable, 3 = Neither Comfortable or Uncomfortable, 4 = Comfortable, and 5 = Very Comfortable.

The last survey question related to likelihood to recommend the device ranged from 1-5 with higher scores indicating a better outcome, where 1 = Very Unlikely, 2 = Unlikely, 3 = Neither Likely Nor Unlikely, 4 - Likely, and 5 = Very Likely.

Participant Comfort Scale SurveyApproximately 2 hours after device placement

Overall comfort on a 5-point Likert scale ranging from 1- 5 with higher scores indicating a better outcome, where 1 = Very Uncomfortable, 2 = Uncomfortable, 3 = Neither Comfortable or Uncomfortable, 4 = Comfortable, and 5 = Very Comfortable.

The last survey question related to likelihood to recommend the device ranged from 1-5 with higher scores indicating a better outcome, where 1 = Very Unlikely, 2 = Unlikely, 3 = Neither Likely Nor Unlikely, 4 - Likely, and 5 = Very Likely.

Ease of Use by Health Care Professional (HCP)Approximately 2 hours after device placement

Ease of use score on a 5-point Likert scale ranging from 1- 5 with higher scores indicating a better outcome, where 1 = Very Difficult, 2 = Somewhat Difficult, 3 = Average Difficulty, 4 = Somewhat Easy, and 5 = Very Easy.

Trial Locations

Locations (1)

USF Health Center for Advanced Medical Learning and Simulation (CAMLS)

🇺🇸

Tampa, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath